Crinetics Pharmaceuticals Inc
F:6Z4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Crinetics Pharmaceuticals Inc
F:6Z4
|
US |
|
S
|
Shanghai Industrial Urban Development Group Ltd
OTC:SIUDF
|
HK |
|
ROKMASTER Resources Corp
F:1RR1
|
CA |
|
C
|
Cranswick PLC
F:0U6
|
UK |
|
W
|
WashTec AG
SWB:WSU
|
DE |
|
H
|
Honghua Group Ltd
F:4HB
|
CN |
|
C
|
China Evergrande Group
SWB:EV1
|
CN |
|
L
|
Landa App LLC
OTC:LWWUS
|
US |
|
J
|
Jalux Inc
F:JB2
|
JP |
|
Mountain Valley MD Holdings Inc
F:20MP
|
CA |
Wall St Price Targets
6Z4 Price Targets Summary
Crinetics Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for 6Z4 is 30.57 EUR with a low forecast of 24.51 EUR and a high forecast of 35.59 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6Z4's stock price target?
Price Target
30.57
EUR
According to Wall Street analysts, the average 1-year price target for 6Z4 is 30.57 EUR with a low forecast of 24.51 EUR and a high forecast of 35.59 EUR.
What is the Revenue forecast for Crinetics Pharmaceuticals Inc?
Projected CAGR
123%
Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 8 years is 123%.
What is the Gross Profit forecast for Crinetics Pharmaceuticals Inc?
Projected CAGR
125%
The compound annual growth rate for Gross Profit over the next 8 years is 125%.
